Departments of Internal Medicine, Nephrology Unit, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Artif Organs. 2009 Oct;33(10):844-54. doi: 10.1111/j.1525-1594.2009.00814.x. Epub 2009 Jul 22.
Patients with end-stage renal disease have a very high prevalence and extent of arterial calcification. A number of studies suggest that similar pathophysiologic mechanisms are responsible for development and progression of calcification of atherosclerotic plaque and bone formation. Fetuin-A is a potent calcification inhibitor and is expressed in bone, with not-yet well-defined functions. The aim of this study was to investigate the relation between bone mineral densitometry parameters, coronary artery calcification, and serum fetuin-A levels. In a cross-sectional design, we included 72 maintenance hemodialysis (HD) patients and 30 age- and gender-matched healthy controls. Serum fetuin-A levels were studied both in maintenance HD patients and healthy controls. Maintenance HD patients had radius, hip, and lumbar spine bone mineral density (BMD) assessed by dual-energy X-ray absorptiometry and coronary artery calcification score (CACS) measured by electron-beam computed tomography. The associations between site-specific BMD parameters, CACS, and serum fetuin-A levels were studied in maintenance HD patients. CACS, mass, and volume of plaques in coronary arteries were significantly higher in patients with a T-score below -2.5 than above in the proximal region of the radius, neck and trochanter of the femur, and the lumbar spine. Mean serum fetuin-A concentration was 0.636 +/- 0.118 g/L in maintenance HD patients and it was less than healthy controls (0.829 +/- 0.100 g/L, P < 0.0001). CACS, mass, and volume of plaques in coronary arteries correlated significantly with the serum fetuin-A levels. Moreover, significant positive correlations were shown between the serum fetuin-A levels, BMD values, and T-scores of proximal radius, neck, and trochanter of the femur, but not with the lumbar spine. The present study demonstrates an association between serum fetuin-A levels, coronary artery calcification, and bone mineral densities--except for the lumbar spine, in maintenance HD patients. However, the results should be interpreted with caution because of the cross-sectional design of the study.
患有终末期肾病的患者存在非常高的动脉钙化发生率和程度。多项研究表明,类似的病理生理机制与动脉粥样硬化斑块钙化和骨形成的发展和进展有关。胎球蛋白-A 是一种有效的钙化抑制剂,在骨中表达,但其功能尚未明确。本研究旨在探讨骨矿物质密度参数、冠状动脉钙化和血清胎球蛋白-A 水平之间的关系。采用横断面设计,纳入 72 名维持性血液透析(HD)患者和 30 名年龄和性别匹配的健康对照者。研究了维持性 HD 患者和健康对照者的血清胎球蛋白-A 水平。通过双能 X 线吸收法评估维持性 HD 患者的桡骨、髋部和腰椎骨矿物质密度(BMD),并通过电子束计算机断层扫描测量冠状动脉钙化评分(CACS)。研究了维持性 HD 患者的特定部位 BMD 参数、CACS 和血清胎球蛋白-A 水平之间的相关性。与桡骨近端、股骨颈和转子以及腰椎的 T 评分>-2.5 相比,CACS、斑块的质量和体积在 T 评分<-2.5 的患者中显著更高。维持性 HD 患者的血清胎球蛋白-A 浓度平均为 0.636±0.118 g/L,低于健康对照组(0.829±0.100 g/L,P<0.0001)。CACS、斑块的质量和体积与血清胎球蛋白-A 水平显著相关。此外,血清胎球蛋白-A 水平与桡骨近端、股骨颈和转子的 BMD 值和 T 评分呈显著正相关,但与腰椎无关。本研究表明,在维持性 HD 患者中,血清胎球蛋白-A 水平、冠状动脉钙化和骨矿物质密度之间存在关联——除了腰椎。然而,由于研究的横断面设计,结果应谨慎解释。